The European Federation for Medicinal Chemistry (EFMC) is an independent association representing medicinal chemistry societies in Europe. Its objective is to advance the science of medicinal chemistry by promoting cooperation and networking, by providing training and mentoring, by rewarding scientific excellence, and by facilitating communication and influencing stakeholders.

Meetings  January 2018 Next

EFMC Sponsorship rules can be found in the by-laws, point E.

  • 18th Meeting of the Spanish Society of Medicinal Chemistry: “New Perspectives in Drug Discovery”

    January 23-26, 2018   Salamanca, Spain

    The Spanish Society of Medicinal Chemistry (SEQT), member of the European Federation for Medicinal Chemistry (EFMC), welcomes you to the 18th meeting “New perspectives in drug discovery”, to be held in Salamanca on January 23-26, 2018.

    This meeting is one of the many events programed to celebrate the 800 years of the University of Salamanca, the oldest university in Spain, founded in 1218. The organizing committee is honoured to warmly invite SEQT members to such an important celebration for our Studii Salamantini and our friendly city of Salamanca, which was declared UNESCO World Heritage Site in 1988.

    The scientific program will include both plenary and invited lectures, as well as short oral communications and flash poster presentations, covering different aspects of drug discovery and development.


    • Ginés Morata, CSIC-Univ. Autónoma de Madrid, Spain
    • Fernanda Borges, University of Porto, Portugal
    • Gabriele Costantino, Università di Parma, Italy
    • Ignacio García-Ribas, Takeda Pharmaceutical International Co., Spain
    • Maria Ángeles Martínez-Grau, DCRT Spain, Lilly, S.A., Spain
    • Juan Carlos Morales, CSIC, Granada, Spain
    • Sergio Moreno, CSIC-University of Salamanca, Spain
    • Christa Müller, Bonn Pharmaceutical Institute, Germany
    • David K. Smith, University of York, United Kingdom

    Early Registration: until November 15, 2017

    For more information please contact: or visit

  • 1st Alpine Winter Conference on Medicinal and Synthetic Chemistry

    January 28 - February 1, 2018    St Anton, Austria

    The “Alpine Winter Conference on Medicinal and Synthetic Chemistry” exposes attending scientists to cutting edge synthetic and medicinal chemistry as well as latest developments in technologies that foster innovation in drug discovery. The main target audience for this highly interdisciplinary meeting will include medicinal and synthetic chemists, as well as related drug discovery disciplines from both industry and academia as well as graduate/undergraduate students and postdocs.

    In the spirit of Keystone and Gordon conferences as well as the MBCF (Medicinal and Bioorganic Chemistry Foundation) conference in Steamboat Springs, the format of this meeting provides ample opportunity for attendees to informally interact. The aim is to strengthen existing networks and create new contacts.

    The Conference topics will include:

    • Addressing Preclinical Toxicity – Approaches and Lessons Learned (with panel discussion)
    • Advances in Lead Generation
    • Advances in Synthetic Methods
    • Alternative Modalities
    • Challenges and Opportunities in Fragment Based Drug Discovery
    • Chemical Biology in Drug and Target Discovery
    • Late Stage Functionalization

    Full programme and list of speakers are now available.

    Deadline for abstract submission for poster: November 20, 2017

    Scientific Organising Committee

    Dr Klemens HOEGENAUER (Novartis Institutes for BioMedical Research, Basel, Switzerland)
    Dr Karl Heinz KRAWINKLER (Novartis Institutes for BioMedical Research, Basel, Switzerland)
    Dr Antonia STEPAN (Pfizer, Cambridge, United States)

    For more information on the conference, please visit the regularly updated website:

  • 25th Young Research Fellows Meeting

    March 5-7, 2018   Orléans, France

    The YRFM Young Research Fellows Meeting is an initiative of the French Medicinal Chemistry Society (SCT). The 25th edition will take place at the University of Orléans (Hall Sully, department DEG, Law, Economics and Management) during three days (March, 5-7th, 2018).
    This meeting will bring together young European scientists (PhD students, post-doctoral fellows and young academic/industrial confirmed researchers) and will give them the opportunity to present and discuss the latest innovations and future trends in Medicinal Chemistry.
    The topics presented cover all aspects of research in medicinal chemistry: the research and validation of biological targets of therapeutic interest, screening, design, development candidates, chemical biology, medicinal chemistry, pharmacokinetics, metabolism and toxicity (ADME-T: absorption, distribution, metabolism, excretion, toxicity).
    Confirmed speakers:

    • Dr A. Ates, UCB Pharma , Belgium
    • Prof. D. Cantillo, University of Graz , Austria
    • Dr F. Marion, Pierre Fabre Laboratories, France
    • Dr P.A. Driguez, Sanofi , France
    • Prof. N. Willand, University of Lille 2, France

    Many prestigious prizes will be attributed (SCT, ACS, EFMC) for best oral communications, and posters.

    The deadline for the Early-bird registration is the 8th January 2018.

    For more information please contact or visit

    Organised by : Société de Chimie Thérapeutique (France)

  • The BMCS Mastering MedChem IV: 4th RSC-BMCS Symposium on Mastering Medicinal Chemistry

    March 14, 2018   Glasgow, United Kingdom

    Mastering Medicinal Chemistry IV is the latest in an ongoing series of conferences intended to provide expert advice and guidance to new practitioners in the field of drug discovery. It has been said that "there are two types of drug discovery programmes: those that hit serious problems and those that are going to hit serious problems". Anticipating and preparing for such problems thus accelerates the delivery of new medicines: this event will feature presentations from experienced 'drug-hunters' in both industry and academia, who will talk about the challenges faced in modern drug discovery, and will share the good practices common to all successful medicinal chemists.


    Prof. Stuart Conway, University of Oxford, United Kingdom
    Prof. Ian Gilbert, University of Dundee, United Kingdom
    Dr Nicole Hamblin, Charles River, United Kingdom
    Dr Craig Johnstone, Evotec, United Kingdom
    Prof. Adam Nelson, University of Leeds, United Kingdom
    Prof. Chris Schofield, University of Oxford, United Kingdom
    Dr Iain Simpson, AstraZeneca, United Kingdom

    The closing date for abstract submission is February 20, 2018.

    Contact person: Mrs Maggi Churchouse
    Tel: +44 (0)1359 221004

  • Medicinal Chemistry of Antimicrobials to Antiparasitics

    March 23, 2018   Utrecht, The Netherlands

    Confirmed speakers:

    • Heike Brötz-Oesterhelt, University of Tübingen, Germany
    • Koen Dechering, TropiQ, The Netherlands
    • Beat Ernst, University of Basel, Switzerland
    • Rob Leurs,  VU University Amsterdam, The Netherlands
    • Nathaniel Martin, Utrecht University, The Netherlands
    • Gilles van Wezel, Leiden University, The Netherlands

    For more information please contact:
    Prof. Dr. F.J. Dekker

  • 54th International Conference on Medicinal Chemistry (RICT 2018)

    July 4-6, 2018   Strasbourg, France

    The French Medicinal Chemistry Society (Société de Chimie Thérapeutique - SCT) is pleased to invite you to Strasbourg, France on July 4-6, 2018 for the 54th edition of the International Conference on Medicinal Chemistry (RICT 2018).

    The congress will be devoted to “Interfacing Chemical Biology and Drug Discovery”.


    1) New opportunities for metabolic and cardiovascular diseases

    • Exploring novel pathways for the next generation drugs
    • Non-small molecule approaches in metabolic & cardiovascular disorders

    2) New breakthroughs in GPCR structure, function and their impact on drug discovery

    • Exploring GPCR heterodimers as a source of drugs
    • New biophysics developments in GPCR structure and function

    3) New modalities for challenging targets in drug discovery

    • Exploring novel chemical space: scaffolds inspired by nature, conjugates, alternative scaffolds, oligonucleotides, macrocyclics and constrained peptides
    • Tackling biological targets from different angles: protein degradation (PROTAC)

    4) Chemical biology in drug discovery: visualizing biological processes

    • Imaging biological targets and cellular processes
    • Probing biological systems with small molecules

    5) Tackling challenges in drug delivery and formulation

    • Making the insoluble soluble
    • Novel solutions to stabilize & deliver peptides/proteins

    6) Case studies: from target validation to novel drugs (all therapeutic areas included)

    Contact person: Dr Dominique Bonnet
    Tel: +33(0)368854236
    Fax: +33(0)369854310

    Organised by : Société de Chimie Thérapeutique (France)

  • 22nd European Symposium on Quantitative Structure-Activity Relationship (22nd EuroQSAR)

    September 16-20, 2018   Thessaloniki, Greece

    The European Quantitative Structure-Activity Relationships (EuroQSAR) Symposia are major scientific events that have been organized in different cities of Europe since 1973. They have the fascinating scope to promote and disseminate advances in rational approaches in drug design and discovery and ensure a worldwide attendance of prominent scientists from both academia and industry.

    The 22nd EuroQSAR 2018 symposium, entitled “Translational and Health Informatics: Implications for Drug Discovery”, will take place September 16-20, 2018 in Thessaloniki, Greece. It is a Turkish-Greek co-organization and an EFMC sponsored event.

    The symposium will focus on:

    • ADME Prediction and Computational Toxicology for Safer and Efficacious Drugs
    • Big Data Analysis, Cloud Resources and Precision Medicine
    • Binding Kinetics in Drug Discovery
    • Biotechnology Targeted Drug Discovery
    • Cheminformatics / Pharmacoinformatics in the Era of Biological Complexity
    • Computational Biology and Quantum Enzymology
    • Computational Methods for Nanotechnology in Drug Discovery
    • Epigenetic Drug Targets
    • Homology Modelling for Drug Discovery
    • Ligand-Based and Structure-Based Approaches to Drug Design
    • Modelling of Natural Drugs
    • Molecular Dynamic Simulations and Related Methods
    • Multi-Targeting Drug Design
    • New avenues in QSAR Methodology and Applications
    • Protein Target Dynamics for Drug Discovery
    • Targeting Protein-Protein Interactions

    The scientific program of the Symposium will include plenary lectures, keynote lectures, oral communications, companies' workshops, poster presentations and a commercial exhibition.

    Organised by : Hellenic Society of Medicinal Chemistry (Greece)

Job portal

Synthetic Organic and Medicinal Chemists, Vernalis Research: Chemistry, Cambridge, United Kingdom
read more

Medicinal / Synthetic Organic Chemists, Concept Life Sciences: Drug Discovery, Sandwich, Kent, United Kingdom
read more

Job portal page

Follow us on Facebook

Follow us on Twitter

Follow us on LinkedIn

ChemBridgeBoehringer IngelheimNovartisProf Dr W. Th. Nauta FoundationPfizerServierRoche
 Prous Institute for Biomedical ResearchUCBJanssen R&DBayerMerck